David Sockolof is the Chief Financial Officer at ProSciento, Inc. Mr. Sockolof is a finance and operations executive with deep experience in corporate growth strategies. His career within the clinical research industry spans more than 20 years, including his role as Executive Director of Resource and Process Optimization at Labcorp Drug Development where he provided leadership in financial forecasting, expense management, and global resource management.
Prior to his position at Labcorp, Mr. Sockolof held a number of leadership roles at PRA Health Sciences, including Vice President of Finance and Business Operations and, prior to that, Director of Business Operations. During his tenure at PRA, his contributions were instrumental in the company’s evolution from a mid-size company to a leading global CRO, including the implementation of strategic financial frameworks and improved systems for proposals and pricing, project finance and global vendor management. He received his MBA from George Washington University.
